123 related articles for article (PubMed ID: 38295753)
21. Single-cell RNA-seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63.
Tanaka N; Katayama S; Reddy A; Nishimura K; Niwa N; Hongo H; Ogihara K; Kosaka T; Mizuno R; Kikuchi E; Mikami S; Miyakawa A; Arenas E; Kere J; Oya M; Uhlén P
Cancer Med; 2018 Dec; 7(12):6193-6204. PubMed ID: 30367559
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling.
Long X; Xiong W; Zeng X; Qi L; Cai Y; Mo M; Jiang H; Zhu B; Chen Z; Li Y
Cell Death Dis; 2019 May; 10(5):375. PubMed ID: 31076571
[TBL] [Abstract][Full Text] [Related]
23. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer.
Hayden A; Douglas J; Sommerlad M; Andrews L; Gould K; Hussain S; Thomas GJ; Packham G; Crabb SJ
Urol Oncol; 2014 Aug; 32(6):806-14. PubMed ID: 24837013
[TBL] [Abstract][Full Text] [Related]
24. BRD4 promotes the migration and invasion of bladder cancer cells through the Sonic hedgehog signaling pathway and enhances cisplatin resistance.
Liu T; Zhang Z; Wang C; Huang H; Li Y
Biochem Cell Biol; 2022 Apr; 100(2):179-187. PubMed ID: 35167374
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance.
Su Y; Yang W; Jiang N; Shi J; Chen L; Zhong G; Bi J; Dong W; Wang Q; Wang C; Lin T
Int J Biol Sci; 2019; 15(2):441-452. PubMed ID: 30745833
[TBL] [Abstract][Full Text] [Related]
26. Cigarette Smoke Containing Acrolein Contributes to Cisplatin Resistance in Human Bladder Cancers through the Regulation of HER2 Pathway or FGFR3 Pathway.
Hong JH; Tong ZJ; Wei TE; Lu YC; Huang CY; Huang CY; Chiang CH; Jaw FS; Cheng HW; Wang HT
Mol Cancer Ther; 2022 Jun; 21(6):1010-1019. PubMed ID: 35312783
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling.
Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y
FEBS J; 2014 Apr; 281(7):1750-8. PubMed ID: 24495014
[TBL] [Abstract][Full Text] [Related]
28. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms.
Li F; Zheng Z; Chen W; Li D; Zhang H; Zhu Y; Mo Q; Zhao X; Fan Q; Deng F; Han C; Tan W
Drug Resist Updat; 2023 May; 68():100938. PubMed ID: 36774746
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy.
Li H; Yu G; Shi R; Lang B; Chen X; Xia D; Xiao H; Guo X; Guan W; Ye Z; Xiao W; Xu H
Mol Cancer; 2014 Jan; 13():8. PubMed ID: 24423412
[TBL] [Abstract][Full Text] [Related]
30. ARID1A Inactivation Increases Expression of circ0008399 and Promotes Cisplatin Resistance in Bladder Cancer.
Jiang YK; Shuai YJ; Ding HM; Zhang H; Huang C; Wang L; Sun JY; Wei WJ; Xiao XY; Jiang GS
Curr Med Sci; 2023 Jun; 43(3):560-571. PubMed ID: 37142816
[TBL] [Abstract][Full Text] [Related]
31. Aldehyde dehydrogenase 6 family member A1 negatively regulates cell growth and to cisplatin sensitivity in bladder cancer.
Guo Q; Zhang T; Gong Y; Tao Y; Gao Y; Wang Y; Tian J; Zhang S; Wang H; Rodriguez R; Wang Z
Mol Carcinog; 2022 Jul; 61(7):690-701. PubMed ID: 35472711
[TBL] [Abstract][Full Text] [Related]
32. The role of c-FLIP in cisplatin resistance of human bladder cancer cells.
Lee S; Yoon CY; Byun SS; Lee E; Lee SE
J Urol; 2013 Jun; 189(6):2327-34. PubMed ID: 23313194
[TBL] [Abstract][Full Text] [Related]
33. Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-κB signal-dependent and signal-independent manner.
Sun Y; Guan Z; Zhao W; Jiang Y; Li Q; Cheng Y; Xu Y
Int J Oncol; 2017 Oct; 51(4):1219-1226. PubMed ID: 28791405
[TBL] [Abstract][Full Text] [Related]
34. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
Seiler R; Oo HZ; Tortora D; Clausen TM; Wang CK; Kumar G; Pereira MA; Ørum-Madsen MS; Agerbæk MØ; Gustavsson T; Nordmaj MA; Rich JR; Lallous N; Fazli L; Lee SS; Douglas J; Todenhöfer T; Esfandnia S; Battsogt D; Babcook JS; Al-Nakouzi N; Crabb SJ; Moskalev I; Kiss B; Davicioni E; Thalmann GN; Rennie PS; Black PC; Salanti A; Daugaard M
Eur Urol; 2017 Jul; 72(1):142-150. PubMed ID: 28408175
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of intracellular platinum is correlated with intrinsic cisplatin resistance in human bladder cancer cell lines.
Koga H; Kotoh S; Nakashima M; Yokomizo A; Tanaka M; Naito S
Int J Oncol; 2000 May; 16(5):1003-7. PubMed ID: 10762637
[TBL] [Abstract][Full Text] [Related]
36. Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
Sekino Y; Sakamoto N; Ishikawa A; Honma R; Shigematsu Y; Hayashi T; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
Oncol Rep; 2019 May; 41(5):3111-3118. PubMed ID: 30864720
[TBL] [Abstract][Full Text] [Related]
37. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
[TBL] [Abstract][Full Text] [Related]
38. Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation.
Chen X; Xie W; Gu P; Cai Q; Wang B; Xie Y; Dong W; He W; Zhong G; Lin T; Huang J
Sci Rep; 2015 Feb; 5():8293. PubMed ID: 25656485
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1.
Lin J; Zhang Q; Lu Y; Xue W; Xu Y; Zhu Y; Hu X
PLoS One; 2014; 9(5):e98418. PubMed ID: 24846322
[TBL] [Abstract][Full Text] [Related]
40. MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma.
Ho IL; Kuo KL; Liu SH; Chang HC; Hsieh JT; Wu JT; Chiang CK; Lin WC; Tsai YC; Chou CT; Hsu CH; Pu YS; Shi CS; Huang KH
Sci Rep; 2015 Nov; 5():16948. PubMed ID: 26592553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
